Evidence that partly supports the condition
Operating cash and per-share earnings are both still growing.
Nine-month operating cash flow $12.32bn, up 23% · diluted shares up 1.3%Q3 adjusted EPS rose to $1.24 from $1.13 and nine-month adjusted EPS to $3.47 from $3.17, with 2026 guidance of $3.92–4.02 reaffirmed and the high end targeted. Diluted weighted-average shares were 2,098m against 2,071m a year earlier, so the growth has not yet been diluted away, and FPL grew regulatory capital employed by about 9.2% (release pp.1, 3, 7–10, 13).
Evidence that can still overturn it
The funding gap widened, and it was filled mostly with debt.
Investment exceeded operating cash by $15.2bn in nine months · long-term debt up $12.9bn since DecemberCapital expenditures and NEER investments totalled $27.55bn against $12.32bn of operating cash flow, before $3.91bn of dividends; a year earlier the gap was $9.34bn. Long-term debt including the current portion rose from $93.06bn to $105.96bn, while common stock and equity-unit issuance was $0.97bn. Q3 GAAP EPS of $2.28 also included $1.43 per share of non-qualifying hedge gains that adjusted EPS excludes (release pp.7, 11–14).